Curatolo Massimiliano, La Bianca Giuseppe, Cosentino Giuseppe, Baschi Roberta, Salemi Giuseppe, Talotta Rossella, Romano Marcello, Triolo Giovanni, De Tommaso Marina, Fierro Brigida, Brighina Filippo
Department of Experimental Biomedicine and Clinical Neuroscience (BioNec), Neurology Section, University of Palermo, Italy.
Rheumatology Unit, ASST-Fatebenefratelli- L. Sacco University Hospital, Milan, Italy.
Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):100-105. Epub 2017 Jun 29.
Fibromyalgia (FM) is a clinical syndrome characterised by widespread musculoskeletal pain, chronic fatigue, cognitive deficits, and sleep and mood disorders. The effectiveness of most pharmacological treatments is limited, and there is a need for new, effective and well-tolerated therapies. It has recently been shown that transcranial direct-current stimulation (tDCS) of the motor cortex reduces pain, and that tDCS of the dorso-lateral prefrontal cortex (DLPFC) improves anxiety, depression and cognitive impairment in FM patients. The new technique of transcranial random noise stimulation (tRNS) using randomly changing alternating currents has very recently been shown to improve working memory and pain in limited series of patients with FM or neuropathic pain. The aim of this study was to investigate the clinical effects of primary motor cortex (M1) tRNS in FM patients.
Twenty female FM patients aged 26-67 years were randomised to undergo active (real) or placebo (sham) tRNS sessions on five days a week (Monday-Friday) for two weeks. Each patient was evaluated before and after treatment using a visual analogue scale (VAS), the Fibromyalgia Impact Questionnaire (FIQ), the Hospital Anxiety and Depression Scale (HADS), the Trail Making Test (TMT), the Rey Auditory Verbal Learning Test (RAVLT), the Forward and Backward Digit Span test, and the FAS verbal fluency test.
In comparison with sham treatment, active tRNS of M1 induced a general improvement in the clinical picture of FM, with a significant reduction in pain, depression, anxiety and FIQ scores and a significant improvement in TMT (A), RAVLT and FAS scores.
These findings suggest that tRNS of M1 can be very effective in relieving FM symptoms. Unlike motor cortex tDCS, it seems to counteract both pain and cognitive disturbances, possibly because the invoked mechanism of stochastic resonance synchronises neural firing and thus leads to more widespread and lasting effects.
纤维肌痛(FM)是一种临床综合征,其特征为广泛的肌肉骨骼疼痛、慢性疲劳、认知缺陷以及睡眠和情绪障碍。大多数药物治疗的效果有限,因此需要新的、有效且耐受性良好的疗法。最近有研究表明,对运动皮层进行经颅直流电刺激(tDCS)可减轻疼痛,而对背外侧前额叶皮层(DLPFC)进行tDCS可改善FM患者的焦虑、抑郁和认知障碍。经颅随机噪声刺激(tRNS)这一使用随机变化的交流电的新技术,最近在有限的FM或神经性疼痛患者系列中显示可改善工作记忆和疼痛。本研究的目的是调查对初级运动皮层(M1)进行tRNS对FM患者的临床效果。
20名年龄在26至67岁之间的女性FM患者被随机分为两组,一组接受主动(真实)tRNS治疗,另一组接受安慰剂(假)tRNS治疗,每周五天(周一至周五),共两周。在治疗前后,使用视觉模拟量表(VAS)、纤维肌痛影响问卷(FIQ)、医院焦虑抑郁量表(HADS)、连线测验(TMT)、雷伊听觉词语学习测验(RAVLT)、顺背和倒背数字广度测验以及FAS言语流畅性测验对每位患者进行评估。
与假治疗相比,对M1进行主动tRNS可使FM的临床症状总体得到改善,疼痛、抑郁、焦虑和FIQ评分显著降低,TMT(A)、RAVLT和FAS评分显著提高。
这些发现表明,对M1进行tRNS在缓解FM症状方面可能非常有效。与运动皮层tDCS不同,它似乎既能对抗疼痛又能对抗认知障碍,这可能是因为所引发的随机共振机制使神经放电同步,从而产生更广泛和持久的效果。